A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus This was a study designed to evaluate the efficacy of multiple doses of an investigational drug, NBI-6024, in adult (18 to 35 years of age) and adolescent (10 to 17 years of age) patients ...

• Pays Canada, Czech Republic, Finland, France, Germany, South Africa, Spain, United Kingdom
• Organes Aucun
• Spécialités Aucune